Alliancebernstein L.P. Mirati Therapeutics, Inc. Transaction History

Alliancebernstein L.P.

$287 Billion
Q3 2024

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Feb 14, 2024	BUY	$41.99 - $62.38 $26 Million - $38.6 Million	618,858 Added 517.32%	738,486 $43.4 Million
Q3 2023 Nov 14, 2023	SELL	$27.8 - $45.35 $552,469 - $901,240	-19,873 Reduced 14.25%	119,628 $5.21 Million
Q2 2023 Aug 15, 2023	BUY	$36.13 - $49.49 $2.45 Million - $3.36 Million	67,858 Added 94.72%	139,501 $5.04 Million
Q1 2023 May 15, 2023	BUY	$36.54 - $54.26 $1.47 Million - $2.19 Million	40,275 Added 128.4%	71,643 $2.66 Million
Q4 2022 Feb 14, 2023	SELL	$41.27 - $98.62 $536 - $1,282	-13 Reduced 0.04%	31,368 $1.42 Million
Q3 2022 Nov 15, 2022	SELL	$59.5 - $86.7 $370,030 - $539,187	-6,219 Reduced 16.54%	31,381 $2.19 Million
Q2 2022 Aug 15, 2022	BUY	$39.16 - $88.71 $78,554 - $177,952	2,006 Added 5.64%	37,600 $2.52 Million
Q1 2022 May 13, 2022	SELL	$75.82 - $150.97 $1.57 Million - $3.12 Million	-20,651 Reduced 36.72%	35,594 $2.93 Million
Q4 2021 Feb 14, 2022	BUY	$132.01 - $190.29 $1.12 Million - $1.62 Million	8,496 Added 17.79%	56,245 $8.25 Million
Q3 2021 Nov 10, 2021	BUY	$132.13 - $177.45 $1.16 Million - $1.56 Million	8,808 Added 22.62%	47,749 $8.45 Million
Q2 2021 Jul 30, 2021	SELL	$144.0 - $179.73 $5.67 Million - $7.07 Million	-39,357 Reduced 50.27%	38,941 $6.29 Million
Q1 2021 May 06, 2021	SELL	$158.92 - $221.61 $63,567 - $88,644	-400 Reduced 0.51%	78,298 $13.4 Million
Q4 2020 Feb 08, 2021	BUY	$162.05 - $240.27 $772,492 - $1.15 Million	4,767 Added 6.45%	78,698 $17.3 Million
Q3 2020 Nov 12, 2020	SELL	$113.26 - $167.27 $905,173 - $1.34 Million	-7,992 Reduced 9.76%	73,931 $12.3 Million
Q2 2020 Aug 13, 2020	BUY	$72.01 - $120.39 $1.48 Million - $2.47 Million	20,500 Added 33.38%	81,923 $9.35 Million
Q1 2020 May 14, 2020	BUY	$69.78 - $116.21 $160,494 - $267,283	2,300 Added 3.89%	61,423 $4.72 Million
Q4 2019 Feb 18, 2020	BUY	$70.76 - $128.86 $70,760 - $128,860	1,000 Added 1.72%	59,123 $7.62 Million
Q2 2019 Aug 14, 2019	BUY	$59.49 - $104.71 $1.36 Million - $2.39 Million	22,834 Added 64.71%	58,123 $5.99 Million
Q1 2019 May 14, 2019	SELL	$43.65 - $78.95 $3.04 Million - $5.5 Million	-69,611 Reduced 66.36%	35,289 $2.59 Million
Q4 2018 Feb 13, 2019	BUY	$32.0 - $47.43 $2.4 Million - $3.56 Million	75,000 Added 250.84%	104,900 $4.45 Million
Q3 2018 Nov 08, 2018	BUY	$47.1 - $62.7 $23,550 - $31,350	500 Added 1.7%	29,900 $1.41 Million
Q2 2018 Aug 13, 2018	BUY	$26.05 - $52.4 $765,870 - $1.54 Million	29,400 New	29,400 $1.45 Million

Others Institutions Holding MRTX

# of Institutions

Shares Held

3.57M

Call Options Held

Put Options Held

36.6K

View Full List

About Mirati Therapeutics, Inc.

Ticker MRTX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 55,609,800
Description
Mirati Therapeutics, Inc., a clinical-stage oncology company, develops product candidates to address the genetic and immunological promoters of cancer in the United States. The company develops MRTX849, a KRAS G12C inhibitor, which is in Phase 1/2 clinical trial for treating non-small cell lung (NSCL), colorectal, pancreatic, and other cancers; ...

More about MRTX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Account